BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 932 filers reported holding BAXTER INTL INC in Q1 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,819,413 | -16.5% | 313,180 | +0.8% | 0.04% | -7.5% |
| Q2 2023 | $14,153,396 | +25.5% | 310,654 | +11.7% | 0.04% | +17.6% |
| Q1 2023 | $11,281,115 | -46.6% | 278,134 | -32.9% | 0.03% | -50.0% |
| Q4 2022 | $21,130,378 | -14.9% | 414,565 | -10.1% | 0.07% | -13.9% |
| Q3 2022 | $24,825,000 | -33.8% | 460,908 | -21.1% | 0.08% | -19.4% |
| Q2 2022 | $37,513,000 | -10.6% | 584,049 | +7.9% | 0.10% | +12.6% |
| Q1 2022 | $41,975,000 | -54.4% | 541,330 | -49.6% | 0.09% | -51.1% |
| Q4 2021 | $92,115,000 | +10.7% | 1,073,098 | +3.7% | 0.18% | +3.5% |
| Q3 2021 | $83,210,000 | +75.1% | 1,034,561 | +75.2% | 0.17% | +75.5% |
| Q2 2021 | $47,531,000 | +42.3% | 590,451 | +49.0% | 0.10% | +38.0% |
| Q1 2021 | $33,413,000 | +22.7% | 396,176 | +16.8% | 0.07% | +12.7% |
| Q4 2020 | $27,225,000 | -5.2% | 339,289 | -5.0% | 0.06% | -12.5% |
| Q3 2020 | $28,713,000 | -33.7% | 357,039 | -29.0% | 0.07% | -40.0% |
| Q2 2020 | $43,325,000 | +65.7% | 503,194 | +56.3% | 0.12% | +37.9% |
| Q1 2020 | $26,140,000 | -30.1% | 321,960 | -28.0% | 0.09% | -7.4% |
| Q4 2019 | $37,390,000 | -7.6% | 447,144 | -3.3% | 0.09% | -16.1% |
| Q3 2019 | $40,446,000 | +4.0% | 462,404 | -2.6% | 0.11% | +3.7% |
| Q2 2019 | $38,895,000 | -28.2% | 474,907 | -28.7% | 0.11% | -29.9% |
| Q1 2019 | $54,194,000 | +21.5% | 666,507 | -1.7% | 0.15% | +6.2% |
| Q4 2018 | $44,610,000 | -7.2% | 677,751 | +8.7% | 0.14% | +9.0% |
| Q3 2018 | $48,049,000 | +21.1% | 623,291 | +16.0% | 0.13% | +16.7% |
| Q2 2018 | $39,677,000 | +19.0% | 537,331 | +4.8% | 0.11% | +18.8% |
| Q1 2018 | $33,356,000 | +20.0% | 512,852 | +19.2% | 0.10% | +26.3% |
| Q4 2017 | $27,801,000 | +3.4% | 430,086 | +0.4% | 0.08% | -3.8% |
| Q3 2017 | $26,881,000 | +11.1% | 428,390 | +7.2% | 0.08% | +1.3% |
| Q2 2017 | $24,192,000 | +54.6% | 399,602 | +32.4% | 0.08% | +30.0% |
| Q1 2017 | $15,652,000 | +43.6% | 301,822 | +22.8% | 0.06% | +27.7% |
| Q4 2016 | $10,897,000 | -21.1% | 245,753 | -15.3% | 0.05% | -13.0% |
| Q3 2016 | $13,807,000 | +0.6% | 290,053 | -4.4% | 0.05% | -1.8% |
| Q2 2016 | $13,718,000 | -7.9% | 303,353 | -16.4% | 0.06% | -5.2% |
| Q1 2016 | $14,898,000 | +4.2% | 362,663 | -3.3% | 0.06% | +5.5% |
| Q4 2015 | $14,304,000 | +7.1% | 374,933 | -7.7% | 0.06% | +5.8% |
| Q3 2015 | $13,351,000 | -71.5% | 406,423 | -39.3% | 0.05% | -68.3% |
| Q2 2015 | $46,827,000 | +3.0% | 669,633 | +0.9% | 0.16% | +4.5% |
| Q1 2015 | $45,478,000 | -8.1% | 663,913 | -1.7% | 0.16% | -7.6% |
| Q4 2014 | $49,485,000 | +5.9% | 675,193 | +3.7% | 0.17% | +0.6% |
| Q3 2014 | $46,725,000 | -0.3% | 651,033 | +0.4% | 0.17% | 0.0% |
| Q2 2014 | $46,876,000 | +0.5% | 648,353 | +2.2% | 0.17% | -5.1% |
| Q1 2014 | $46,665,000 | +6.6% | 634,213 | +0.8% | 0.18% | +6.0% |
| Q4 2013 | $43,758,000 | +58.4% | 629,163 | +49.6% | 0.17% | +47.4% |
| Q3 2013 | $27,621,000 | -12.5% | 420,481 | -7.7% | 0.11% | -13.6% |
| Q2 2013 | $31,573,000 | – | 455,793 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |